Skip to content

Study · Not a test of the peptide alone · 1994

3 results

Oestradiol concentration and the development of the uterine oxytocin receptor and oxytocin-induced PGF2 alpha release in ewes.

Beard AP, Lamming GE

Journal of reproduction and fertility1 Mar 1994Cited by 28 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Oxytocin.

  1. 01AnimalNot a test of Oxytocin aloneAnimal study (in vivo)Mechanism

    In ovariectomised ewes given an oxytocin challenge on day 10 of a simulated cycle, the mean PGFM response was not changed by the oestradiol concentration given.

    In plain wordsIn ewes, the amount of oestradiol given did not change the prostaglandin metabolite response to an oxytocin dose on day 10.

    Peptide
    Oxytocin
    Outcome
    No significant changePGFM response to oxytocin challenge on day 10
    Study

    sheepn: not reported in source

    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Source sentences

    Summary
    On day 10 only one ewe in each group exhibited a PGFM response to oxytocin, and the mean response was unaffected by the concentration of oestradiol administered.
    2 context sentences
    Summary · context
    Ewes were then treated for up to 12 days with progesterone (24 mg day-1 maximum) with or without oestradiol (both hormones administered in 1 ml of corn oil i.m. at 8 h intervals) in a pattern known to simulate natural plasma profiles of the oestrous cycle.
    Summary · context
    Subgroups of four ewes from each treatment group were given 1 microgram of oxytocin (i.v.) on day 10, 11 or 12 of the simulated cycle, and endometrial oxytocin receptor concentrations were determined in samples collected within 3 h of oxytocin administration.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

  2. 02AnimalNot a test of Oxytocin aloneAnimal study (in vivo)Mechanism

    In ovariectomised ewes on days 11 and 12 of a simulated cycle, oestradiol concentration significantly changed the PGFM release pattern after an oxytocin challenge, and high oestradiol caused a rapid rise in PGFM.

    In plain wordsIn ewes, high oestradiol caused a fast rise in the prostaglandin metabolite after an oxytocin dose on days 11 and 12.

    Peptide
    Oxytocin
    Outcome
    IncreasePGFM release pattern after oxytocin on days 11 and 12
    Study

    sheepn: not reported in source

    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Source sentences

    Summary
    On days 11 and 12 there was a significant effect of oestradiol concentration (P < 0.05) on the pattern of PGFM release in response to oxytocin, the high oestradiol concentration causing a rapid increase in the concentration of PGFM following oxytocin administration.
    2 context sentences
    Summary · context
    Ewes were then treated for up to 12 days with progesterone (24 mg day-1 maximum) with or without oestradiol (both hormones administered in 1 ml of corn oil i.m. at 8 h intervals) in a pattern known to simulate natural plasma profiles of the oestrous cycle.
    Summary · context
    Subgroups of four ewes from each treatment group were given 1 microgram of oxytocin (i.v.) on day 10, 11 or 12 of the simulated cycle, and endometrial oxytocin receptor concentrations were determined in samples collected within 3 h of oxytocin administration.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

  3. 03AnimalNot a test of Oxytocin aloneAnimal study (in vivo)Mechanism

    In ovariectomised ewes on day 12 of a simulated cycle, oestradiol concentration correlated positively with the mean PGFM response to an oxytocin challenge.

    In plain wordsIn ewes, higher oestradiol went with a larger prostaglandin metabolite response to an oxytocin dose on day 12.

    Peptide
    Oxytocin
    Outcome
    IncreaseCorrelation of oestradiol concentration with PGFM mean response on day 12
    Study

    sheepn: not reported in source

    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Source sentences

    Summary
    On day 12 the oestradiol concentration was positively correlated with the PGFM mean response (P < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
    2 context sentences
    Summary · context
    Ewes were then treated for up to 12 days with progesterone (24 mg day-1 maximum) with or without oestradiol (both hormones administered in 1 ml of corn oil i.m. at 8 h intervals) in a pattern known to simulate natural plasma profiles of the oestrous cycle.
    Summary · context
    Subgroups of four ewes from each treatment group were given 1 microgram of oxytocin (i.v.) on day 10, 11 or 12 of the simulated cycle, and endometrial oxytocin receptor concentrations were determined in samples collected within 3 h of oxytocin administration.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:51 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.